Trending...
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
CLEVELAND, Oct. 21, 2024 ~ As the rates of colorectal cancer continue to rise among younger Americans, Reese Pharmaceutical has announced the launch of the second phase of their "Know Your CRC History" campaign. The campaign, also known as #MyCRCHistory, aims to empower families to have open discussions about their colorectal cancer health history during holiday gatherings.
The main focus of this initiative is to educate the public about the increasing accessibility of at-home tests, specifically ColoTest. This at-home fecal immunochemical test (FIT) is now available for purchase in over 7,000 CVS Pharmacy stores nationwide and online at CVS.com. In addition to Walmart and Amazon, this non-invasive test can be used annually by individuals of any age to quickly detect hidden blood in the stool, which may be an indication of colorectal cancer.
According to Jeffrey Reese, President of Reese Pharmaceutical, "The holidays provide a unique opportunity to discuss family health history. This knowledge empowers individuals to get screened earlier and more frequently, helping to minimize their risk." He also emphasizes that with the increased accessibility of ColoTest, taking the first step towards early detection has never been easier and could ultimately save lives.
More on Ohio Pen
The American Cancer Society reports that approximately 20,000 people under the age of 50 are diagnosed with colorectal cancer each year. It is now the leading cause of cancer deaths among men in this age group and the second leading cause for women under 50. Early screening is crucial for those with a family history as they may need to start screenings before the recommended age of 45.
A recent study by Kaiser Permanente found that FIT test screening can reduce the overall risk of colon cancer death by 33%. Despite these proven benefits, FIT testing is still considered underutilized. The #MyCRCHistory campaign aims to bridge this gap in knowledge. It was launched after a survey conducted by Reese Pharmaceutical revealed that 80% of adults are unaware of their first-degree relatives' history with colorectal cancer.
To help families better understand their personal risk, the Colorectal Cancer Alliance offers a quick and easy online quiz. This quiz takes users through their family history, risk factors, and symptoms to determine their screening needs. The quiz can be found at quiz.getscreened.org.
For more information on ColoTest and how you can take proactive steps in your colorectal health, visit Reese Pharmaceutical's website. With the holiday season approaching, it is important for families to have open discussions about their health history and take advantage of the increasing accessibility of at-home tests like ColoTest. Early detection is key in fighting against colorectal cancer and this campaign aims to empower individuals to take control of their health.
The main focus of this initiative is to educate the public about the increasing accessibility of at-home tests, specifically ColoTest. This at-home fecal immunochemical test (FIT) is now available for purchase in over 7,000 CVS Pharmacy stores nationwide and online at CVS.com. In addition to Walmart and Amazon, this non-invasive test can be used annually by individuals of any age to quickly detect hidden blood in the stool, which may be an indication of colorectal cancer.
According to Jeffrey Reese, President of Reese Pharmaceutical, "The holidays provide a unique opportunity to discuss family health history. This knowledge empowers individuals to get screened earlier and more frequently, helping to minimize their risk." He also emphasizes that with the increased accessibility of ColoTest, taking the first step towards early detection has never been easier and could ultimately save lives.
More on Ohio Pen
- Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
The American Cancer Society reports that approximately 20,000 people under the age of 50 are diagnosed with colorectal cancer each year. It is now the leading cause of cancer deaths among men in this age group and the second leading cause for women under 50. Early screening is crucial for those with a family history as they may need to start screenings before the recommended age of 45.
A recent study by Kaiser Permanente found that FIT test screening can reduce the overall risk of colon cancer death by 33%. Despite these proven benefits, FIT testing is still considered underutilized. The #MyCRCHistory campaign aims to bridge this gap in knowledge. It was launched after a survey conducted by Reese Pharmaceutical revealed that 80% of adults are unaware of their first-degree relatives' history with colorectal cancer.
To help families better understand their personal risk, the Colorectal Cancer Alliance offers a quick and easy online quiz. This quiz takes users through their family history, risk factors, and symptoms to determine their screening needs. The quiz can be found at quiz.getscreened.org.
For more information on ColoTest and how you can take proactive steps in your colorectal health, visit Reese Pharmaceutical's website. With the holiday season approaching, it is important for families to have open discussions about their health history and take advantage of the increasing accessibility of at-home tests like ColoTest. Early detection is key in fighting against colorectal cancer and this campaign aims to empower individuals to take control of their health.
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
- Centennial Flyers to Become Colorado's First Launch Customer for All-Electric B23 Energic Aircraft
- Fully Accountable Introduces Interactive Accounting Scorecard to Improve Financial Performance
- Pyro Marketing Opens New Digital Marketing Company to Power Growth for Fitness and Ecommerce Brands
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- Warren County Park District Unveils Bold Strategic Plan to Shape Future of Parks and Green Spaces
- Huntington Bancshares Incorporated Announces Second Quarter 2025 Earnings Call Details
- Ringside Talent Provides Finance & Accounting Recruiting to Help Companies Build Strong Teams
- ULGSO Hosts The 2025 Urban Champions Youth Summit: "Lead the Way, Don't Be Led Away"
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
- Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
- Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
- Miami Real Estate Agent Drastically Increases Interest In Homes
- Adostics & Genmega Announce the Introduction of A-POD
- Northwest Bancshares, Inc. Announces Second Quarter 2025 Earnings Call Details
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI